BMY vs MUX · P/E 17, rev $24.46B vs rev $133.3M
Bristol-Myers Squibb Company (BMY) versus McEwen Mining Inc. (MUX) — a side-by-side from cached financials, not a winner call.
Bristol-Myers Squibb Company (BMY) is a drug manufacturers - general company listed on US. It is led by Christopher S. Boerner Ph.D..
McEwen Mining Inc. (MUX) is a other precious metals & mining company listed on US.
Latest reported BMY revenue for 2026-06-30 was $24.46B. Net income was $5.99B. BMY currently screens at market cap $95.36B and trailing P/E 17.5.
Latest reported MUX revenue for 2026-06-30 was $133.3M. Net income was $43.0M. Revenue was up 80.0% from 2026-03-31 to 2026-06-30. MUX currently screens at market cap $613.8M.
BMY currently screens at market cap $95.36B and trailing P/E 17.5. MUX currently screens at market cap $613.8M.
Not investment advice. Open the BMY and MUX stock pages for the full models.
Not investment advice.